Form 4: Bicara Therapeutics CEO Sells Shares
Insider Transaction (Form 4)
Claire Mazumdar, Chief Executive Officer and a Director of Bicara Therapeutics Inc., sold 10,000 shares of common stock on July 10, 2026.
Summary
- Option exercise/conversion: acquired 10,000 Common Stock at $3.79 ($37,898) on July 10, 2026; holds 372,152 after (Direct).
- Open-market sale: disposed of 9,972 Common Stock at $28.42 ($283,367) on July 10, 2026; holds 362,180 after (Direct).
- Open-market sale: disposed of 28 Common Stock at $29.68 ($831) on July 10, 2026; holds 362,152 after (Direct).
- Option exercise/conversion: disposed of 10,000 Stock Option (Right to Buy) on July 10, 2026; holds 120,546 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $284,198 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Claire Mazumdar — Director, Officer (Chief Executive Officer)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-10 | Option exercise/conversion | Common Stock | 10,000 | $4 | $37.9K | 372,152 |
| 2026-07-10 | Open-market sale | Common Stock | 9,972 | $28 | $283.4K | 362,180 |
| 2026-07-10 | Open-market sale | Common Stock | 28 | $30 | $831 | 362,152 |
| 2026-07-10 | Option exercise/conversion | Stock Option (Right to Buy) | 10,000 | — | — | 120,546 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-10 | Option exercise/conversion (10,000 shares) |
| 2026-07-10 | Open-market sale (9,972 shares) |
| 2026-07-10 | Open-market sale (28 shares) |
| 2026-07-10 | Option exercise/conversion (10,000 shares) |
Keywords
insider transaction, Form 4, BCAX, Bicara Therapeutics Inc., bearish, Claire Mazumdar
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.